Case Study

Independent real-world application of Paige Prostate

Grupo Oncoclinicas sought to ascertain whether Paige Prostate could be used as quality control tool, even when applied in a different setting to where it was developed. Paige Prostate was applied to independent, real-world data from Grupo Oncoclinicas, and its sensitivity, specificity, positive predictive values, and negative predictive values were compared to that of 3 pathologists. 

The study found that:

  • At the patient level, Paige Prostate displayed an optimal sensitivity (1.0; CI 0.93–1.0) and NPV (1.0; CI 0.91–1.0).
  • The AI identified 4 cases containing foci of malignancy not previously diagnosed by the local or central pathologists as malignant.

Paige provides results you can rely on. 

Complete the form below to access this case study showcasing real-world use of Paige products.